Finasteride (Proscar, Propecia) and Dutasteride (Avodart, Jalyn): May Increase the Risk of High-Grade Prostate Cancer Health Canada is informing health professionals and the public that the prescription drugs finasteride and dutasteride may be associated with an increased risk of developing a serious form of prostate cancer known as high-grade prostate cancer. [Health Canada] Press Release UC Health’s Community Benefit Tops $3 Billion For the first time, University of California (UC) Health has measured the collective impact it has in caring for uninsured patients, educating tomorrow’s health leaders and advancing science to tackle medicine’s toughest challenges. [University of California] Press Release Province Invests $5 Million in Prostate Centre British Columbia men are to benefit from a $5-million provincial grant to the Vancouver Prostate Centre, a world leader in research and treatment of prostate cancer. [Vancouver Coastal Health Research Institute, Canada] Press Release Academic Urology Prostate Center Receives ACR Accreditation The Prostate Center of Academic Urology has been awarded a three-year term of accreditation in radiation oncology from the American College of Radiology (ACR) and the American Society for Radiation Oncology. [BusinessWire] Press Release OPKO Health Expands Collaboration with Arctic Partners OPKO Health, Inc. announced an expansion of the previously announced exclusive licensing deal with Arctic Partners Ab Oy for two biomarkers in the kallikrein family which used together with prostate specific antigen can reduce the need for prostate biopsies by over 50%. [OPKO Health, Inc.] Press Release Memorial Sloan-Kettering Cancer Center, IBM to Collaborate in Applying Watson Technology to Help Oncologists Memorial Sloan-Kettering Cancer Center and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices. [PRNewswire] Press Release |